comprehensive -WSS

comprehensive

author：knowledge 2025-09-06 02:05:53 - browse：38693

Peter Marks. -- health coverage from STAT — Peter Marks, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration. Susan Walsh-Pool/Getty Images

Peter Marks wants drug developers to ask more stupid questions.

It’s part of the top Food and Drug Administration official’s plan to reinvigorate gene therapy, a field that has struggled despite significant technological advances. Some companies are shelving programs or going out of business, even when they have promising data.

The problems are numerous: The diseases are often exceptionally rare, limiting the potential market. Manufacturing at commercial quality is complex and expensive. Proving a drug works can be difficult, because there may be too few patients to run a traditional randomized study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： For Cytokinetics, FDA rejection of heart drug would help, not hinder

WSS

What to know about the judge who will handle the Trump case

Be careful with at

Timeline: How the deadly wildfires took over Maui day by day

A biotech analyst on neuroscience, placebo effect, not over

Biogen’s boardroom scandal saddles CEO with first crisis

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

hotspot

comprehensive

entertainment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Friends ask where James Watson's attitudes about race came from

Continuity nursing helped my family in our darkest PICU moments

Illinois Supreme Court finds assault weapons ban constitutional

Medical leaders decry Supreme Court decision on affirmative action

Patients, digital health players weigh in on FTC's data privacy plan

Affirmative action in medical school literally saved lives

Police still searching for prisoner who escaped from NYC hospital

Hepatitis C has a cure — but many Americans still lack access to it

The best solution to the drug shortages problem

entertainment

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Aspartame and sugar

Biogen’s boardroom scandal saddles CEO with first crisis

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Be careful with at

entertainment

focus

hotspot

focus